Saotome Kei, McGoldrick Luke L, Ho Jo-Hao, Ramlall Trudy F, Shah Sweta, Moore Michael J, Kim Jee Hae, Leidich Raymond, Olson William C, Franklin Matthew C
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Nat Struct Mol Biol. 2025 Feb;32(2):315-325. doi: 10.1038/s41594-024-01397-1. Epub 2024 Sep 23.
Activation of the chemokine receptor CXCR4 by its chemokine ligand CXCL12 regulates diverse cellular processes. Previously reported crystal structures of CXCR4 revealed the architecture of an inactive, homodimeric receptor. However, many structural aspects of CXCR4 remain poorly understood. Here, we use cryo-electron microscopy to investigate various modes of human CXCR4 regulation. CXCL12 activates CXCR4 by inserting its N terminus deep into the CXCR4 orthosteric pocket. The binding of US Food and Drug Administration-approved antagonist AMD3100 is stabilized by electrostatic interactions with acidic residues in the seven-transmembrane-helix bundle. A potent antibody blocker, REGN7663, binds across the extracellular face of CXCR4 and inserts its complementarity-determining region H3 loop into the orthosteric pocket. Trimeric and tetrameric structures of CXCR4 reveal modes of G-protein-coupled receptor oligomerization. We show that CXCR4 adopts distinct subunit conformations in trimeric and tetrameric assemblies, highlighting how oligomerization could allosterically regulate chemokine receptor function.
趋化因子受体CXCR4被其趋化因子配体CXCL12激活后可调节多种细胞过程。先前报道的CXCR4晶体结构揭示了一种无活性的同源二聚体受体的结构。然而,CXCR4的许多结构方面仍知之甚少。在此,我们使用冷冻电子显微镜来研究人类CXCR4调节的各种模式。CXCL12通过将其N端深深插入CXCR4的正构口袋来激活CXCR4。美国食品药品监督管理局批准的拮抗剂AMD3100的结合通过与七跨膜螺旋束中的酸性残基的静电相互作用而得以稳定。一种强效抗体阻滞剂REGN7663跨CXCR4的细胞外表面结合,并将其互补决定区H3环插入正构口袋。CXCR4的三聚体和四聚体结构揭示了G蛋白偶联受体的寡聚化模式。我们表明,CXCR4在三聚体和四聚体组装中采用不同的亚基构象,突出了寡聚化如何变构调节趋化因子受体功能。